Cadrenal Therapeutics, Inc.

New Filing
CIK: 0001937993·Biotechnology·DELAWARE·Filed: Jul 18, 2023
Total Offering

$7,500,001

Amount Sold

$7,500,001

Investors

1

First Sale

Jul 14, 2023

Offering Details

Type
Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Quang Pham
Related Person
Matthew Szot
Related Person
Douglas Losordo
Related Person
John Murphy
Related Person
STEVEN ZELENKOFSKE
Related Person
GLYNN WILSON
Related Person

Company

Cadrenal Therapeutics, Inc.

822 A1A NORTH, SUITE 306

PONTE VEDRA, FL, 32082

(904) 300-0701

SEC Filing

0001213900-23-057497

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free